In this issue:
Lenvatinib for radioiodine-refractory DTC
KDM1A loss in GIP-dependent PBMAH with Cushing’s syndrome
Outcomes after radioiodine ablation in thyroid cancer
Pituitary surgery as an alternative to dopamine agonists for microprolactinomas
Cardiometabolic outcomes and mortality in patients with adrenal adenomas
LT4 oral solution vs. tablets up to 3 years of age for congenital hypothyroidism
Tolerability and efficacy of long-term medical therapy in primary aldosteronism
Hyperglycaemic emergencies associated with COVID-19 vaccination
LT4, LT3+LT4 and desiccated thyroid extract for hypothyroidism
Thyrotropin receptor antibody levels after thyroidectomy vs. RAI in refractory Graves’ disease
Please login below to download this issue (PDF)